Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer

International Journal of Colorectal Disease

Volumn 28, Issue 1, 2013, Pages 139-147

  Pack, Seung Chul ^a   Kim, Hye Ran ^b   Lim, Sang Woo ^b   Kim, Hwan Young ^b   Ko, Jung Yun ^b   Lee, Ki Sang ^a   Hwang, David ^a   Park, Seong Il ^a   Kang, Hoon ^a   Park, Sang Wook ^c   Hong, Gun Young ^c   Hwang, Se Min ^d   Shin, Myung Geun ^b,d   Lee, Soong ^a  

^a Seonam University   (South Korea)

^b Chonnam National University   (South Korea)

^c Gwangju Christian Hospital   (South Korea)

^d Chonnam National University ^*  (South Korea)

Author keywords

APC; Colorectal cancer methylation; DAPK1; E cadherin; FHIT; SMAD4

Indexed keywords

APC PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; FRAGILE HISTIDINE TRIAD PROTEIN; SMAD4 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; DAPK1 GENE; DNA METHYLATION; E CAD GENE; EPIGENETICS; FEMALE; FHIT GENE; GENE AMPLIFICATION; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RECTUM ADENOMA; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SINGLE STRAND CONFORMATION POLYMORPHISM; SMAD4 GENE; ULCERATIVE COLITIS;

ACID ANHYDRIDE HYDROLASES; ADENOCARCINOMA; ADENOMATOUS POLYPS; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CADHERINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES, APC; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SMAD4 PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84872598584     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1566-8     Document Type: Article

References (28)

1. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH (2009) Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15:6185-6191
2. Kim YS, Deng G (2007) Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia. Gut Liver 1:1-11
3. Kim MS, Lee J, Sidransky D (2010) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29:181-206
4. Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G (2010) Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas. World J Gastroenterol 16(28):3553-3560
5. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351:2704-2714
6. Song K, Fendrick AM, Ladabaum U (2004) Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 126:1270-1279
7. Herrera LJ, Raja S, Gooding WE, El-Hefnawy T, Kelly L, Luketich JD, Godfrey TE (2005) Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem 51:113-118
8. Lofton-Day C, Model F, Devos T et al (2008) DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54:414-423
9. Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M (2009) Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer 9:24
10. Cole AM, Myant K, Reed KR, Ridgway RA, Athineos D, Van den Brink GR, Muncan V, Clevers H, Clarke AR, Sicinski P, Sansom OJ (2010) Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. Cancer Res 70:8149-8158
11. Brock MV, Hooker CM, Ota-Machida E et al (2008) DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 358:1118-1128
12. Kawakami K, Brabender J, Lord RV et al (2000) Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92:1805-1811
13. Druck T, Hadaczek P, Fu TB et al (1997) Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 57:504-512
14. Fong KM, Biesterveld EJ, Virmani A et al (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57:2256-2267
15. Umeto H, Yoshida T, Araki K, Yagishita H, Mikami T, Okayasu I (2009) Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender. J Gastroenterol 44:1036-1045
16. Hao XP, Willis JE, Pretlow TG, Rao JS, MacLennan GT, Talbot IC, Pretlow TP (2000) Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res 60:18-21
17. Mori M, Mimori K, Masuda T, Yoshinaga K, Yamashita K, Matsuyama A, Inoue H (2001) Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma. Cancer Res 61:7379-7382
18. Mady HH, Melhem MF (2002) FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study. Clin Exp Metastasis 19:351-358
19. Miyaki M, Kuroki T (2003) Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 306:799-804
20. Reinacher-Schick A, Baldus SE, Romdhana B, Landsberg S, Zapatka M, Monig SP, Holscher AH, Dienes HP, Schmiegel W, Schwarte-Waldhoff I (2004) Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas. J Pathol 202:412-420
21. Patra SK, Bettuzzi S (2007) Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review). Oncol Rep 17:1279-1290
22. Kinsella AR, Lepts GC, Hill CL, Jones M (1994) Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 12:335-342
23. Gozuacik D, Kimchi A (2006) DAPk protein family and cancer. Autophagy 2:74-79
24. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, Kroemer G (2009) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 16:87-93
25. Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, Tanimoto M (2005) Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 11:1219-1225
26. Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS (2004) Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 10:2284-2288
27. Yang HJ, Liu VW, Wang Y, Chan KY, Tsang PC, Khoo US, Cheung AN, Ngan HY (2004) Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol 93:435-440
28. Tanzer M, Balluff B, Distler J, Hale K, Leodolter A, Rocken C, Molnar B, Schmid R, Lofton-Day C, Schuster T, Ebert MP (2010) Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 5:e9061